Last reviewed · How we verify
NCT03541031
Micronutrients as Adjunctive Treatment for Bipolar Disorder
NA trial testing Micronutrient & Fish oil in Bipolar Disorder in 120 participants. Status unknown.
30 April 2019
Quick facts
| Lead sponsor | Eastern Maine Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 120 |
| Start date | 29 May 2018 |
| Primary completion | 30 April 2019 |
| Estimated completion | 30 June 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Micronutrient & Fish oil
- Olive oil & Safflower oil
Conditions studied
- Bipolar Disorder — all drugs for Bipolar Disorder →
Sponsor
Eastern Maine Medical Center
Who can join
18 and older, any sex, with Bipolar Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the trial is to determine whether a 36-ingredient Micronutrient supplement (primarily vitamins and minerals) and Fish oil (omega-3 fatty acid) supplement improves nutritional status and allows lower doses of conventional medications to be effective for bipolar disorder with fewer side effects, when studied under randomized and fully blinded conditions and compared to a placebo. All participants must live in the vicinity of Bangor, Maine.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventions for the management of obesity in people with bipolar disorder.
Tully A, Smyth S, Conway Y, Geddes J, et al · · 2020 · cited 18× · PMID 32687629 · DOI 10.1002/14651858.cd013006.pub2
Verify or expand the search:
- PubMed search for NCT03541031
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bipolar Disorder
Currently open trials in the same condition.
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT06911931 — Visual Perception in Schizophrenia · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07479758 — Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Out · recruiting
- NCT07140913 — A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03541031 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eastern Maine Medical Center
- Last refreshed: 13 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03541031.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing